Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Catanzaro

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Environmental Health Research|June 7, 2011
Repeated holdout cross-validation of model to estimate risk of Lyme disease by landscape characteristicsElizabeth D Hilborn, Donald G Catanzaro, Laura E Jackson
Antimicrobial Agents and Chemotherapy|May 16, 2019
Using Mycobacterium tuberculosis Single-Nucleotide Polymorphisms To Predict Fluoroquinolone Treatment ResponseMarva Seifert, Edmund Capparelli, Donald G Catanzaro, et al.
Theranostics|April 11, 2022
MicroRNA loaded edible nanoparticles: an emerging personalized therapeutic approach for the treatment of obesity and metabolic disordersF Campolo, G Catanzaro, M A Venneri, et al.
Journal of Clinical Microbiology|April 14, 2017
Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous DrugsSophia B Georghiou, Marva Seifert, Donald G Catanzaro, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 10, 2016
Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, IndiaE Conners, R S Garfein, T C Rodwell, et al.
Journal of Endocrinological Investigation|October 28, 2020
Tissue and circulating microRNAs as biomarkers of response to obesity treatment strategiesG Catanzaro, T Filardi, C Sabato, et al.
Plos One|April 6, 2012
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic reviewSophia B Georghiou, Marisa Magana, Richard S Garfein, et al.
Current Neurovascular Research|September 22, 2010
Human platelets express authentic CB₁ and CB₂ receptorsM V Catani, V Gasperi, G Catanzaro, et al.
The Science of the Total Environment|February 1, 2020
Residential urban tree canopy is associated with decreased mortality during tuberculosis treatment in CaliforniaRobert J Blount, Lisa Pascopella, Pennan Barry, et al.
The European Respiratory Journal|April 7, 2017
Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for <i>Mycobacterium tuberculosis</i>Donald G Catanzaro, Andre P Trollip, Marva Seifert, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Environmental Health Research|June 7, 2011
Repeated holdout cross-validation of model to estimate risk of Lyme disease by landscape characteristicsElizabeth D Hilborn, Donald G Catanzaro, Laura E Jackson
Antimicrobial Agents and Chemotherapy|May 16, 2019
Using Mycobacterium tuberculosis Single-Nucleotide Polymorphisms To Predict Fluoroquinolone Treatment ResponseMarva Seifert, Edmund Capparelli, Donald G Catanzaro, et al.
Theranostics|April 11, 2022
MicroRNA loaded edible nanoparticles: an emerging personalized therapeutic approach for the treatment of obesity and metabolic disordersF Campolo, G Catanzaro, M A Venneri, et al.
Journal of Clinical Microbiology|April 14, 2017
Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous DrugsSophia B Georghiou, Marva Seifert, Donald G Catanzaro, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 10, 2016
Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, IndiaE Conners, R S Garfein, T C Rodwell, et al.
Journal of Endocrinological Investigation|October 28, 2020
Tissue and circulating microRNAs as biomarkers of response to obesity treatment strategiesG Catanzaro, T Filardi, C Sabato, et al.
Plos One|April 6, 2012
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic reviewSophia B Georghiou, Marisa Magana, Richard S Garfein, et al.
Current Neurovascular Research|September 22, 2010
Human platelets express authentic CB₁ and CB₂ receptorsM V Catani, V Gasperi, G Catanzaro, et al.
The Science of the Total Environment|February 1, 2020
Residential urban tree canopy is associated with decreased mortality during tuberculosis treatment in CaliforniaRobert J Blount, Lisa Pascopella, Pennan Barry, et al.
The European Respiratory Journal|April 7, 2017
Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for <i>Mycobacterium tuberculosis</i>Donald G Catanzaro, Andre P Trollip, Marva Seifert, et al.
Pageof 5